Emergent Biosolutions Inc Forecast, price target & analysts
Emergent Biosolutions Inc Target price 2026 - Analyst rating & recommendation
Emergent Biosolutions Inc Classifications & Recommendation
Emergent Biosolutions Inc Price Target
| Target Price | $11.22 |
| Price | $6.37 |
| Potential |
76.14%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Emergent Biosolutions Inc 2027 .
The average Emergent Biosolutions Inc target price is $11.22.
This is
76.14%
register free of charge
$12.60
97.80%
register free of charge
$10.10
58.56%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Emergent Biosolutions Inc to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Emergent Biosolutions Inc stock has an average upside potential 2027 of
76.14%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 742.90 | 663.70 |
| 28.81% | 10.66% | |
| EBITDA Margin | 23.88% | 20.35% |
| 1,619.54% | 14.78% | |
| Net Margin | 7.08% | 2.81% |
| 138.77% | 60.31% |
4 Analysts have issued a sales forecast Emergent Biosolutions Inc 2026 . The average Emergent Biosolutions Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Emergent Biosolutions Inc EBITDA forecast 2026. The average Emergent Biosolutions Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Emergent Biosolutions Inc Analysts have issued a net profit forecast 2026. The average Emergent Biosolutions Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.93 | 0.36 |
| 125.83% | 61.29% | |
| P/E | 17.52 | |
| EV/Sales | 1.16 |
4 Analysts have issued a Emergent Biosolutions Inc forecast for earnings per share. The average Emergent Biosolutions Inc EPS is
This results in the following potential growth metrics and future valuations:
Emergent Biosolutions Inc...
Current Emergent Biosolutions Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 09 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 09 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
